This presentation shares the latest instances of serial innovation in pharmaceutical manufacturing, specifically focusing on the creation of transformative medicines for individuals with serious diseases and high-unmet medical needs. The session highlights successful experiences in small molecule continuous manufacturing for Cystic Fibrosis and explores the transformative impact on manufacturing processes for cell and genetic therapies targeting Sickle Cell Disease, Beta Thalassemia, and Type 1 Diabetes. The presentation provides insight into the technical innovations and breakthroughs that played a crucial role in achieving manufacturing success. Additionally, it underscores the significance of cross-functional collaboration in driving manufacturing innovations and delivering transformative medicines. In this session, you will find out more about 

• The role of serial innovation in manufacturing transformative medicines for serious diseases
• Successful small molecule continuous manufacturing for Cystic Fibrosis
• Recognizing specific technical innovations and breakthroughs instrumental in achieving manufacturing success
• The importance of cross-functional collaboration in driving manufacturing innovations.